Why Medicine Costs So Much Money, Despite Imports from Low-Cost Nations
The Senate Commerce Committee takes the little known, and even less understood, Pharmacy Benefit Manager industry to task for high drug costs.
Pharmaceuticals Are Heavily Outsourced. Can the U.S. Make More of it Here?
The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?
European Pharma Considers Reshoring from India, China. Where’s the US?
The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
Skyrocketing Pharmaceutical Imports to the U.S. Endanger National Security
U.S. pharmaceutical imports have skyrocketed in the last ten years, with imports from China, India and Mexico leading the surge.
India Drug Maker Aurobindo Keeps Getting Poor Grades by the FDA
One of India’s pharmaceutical labs has run afoul of the FDA many times this year. The U.S. is dependent on foreign labs like Aurobindo for its drug supply. Can the government help change that?
BARDA Industry Day: More Money for American Pharma?
A project out of the Department of Health & Human Services promises more domestic supply of locally made vaccines and critical drugs. Will they finally deliver?
China’s Ever-Expanding Orwellian State is a Warning to the US – Congressional Hearing
The Congressional-Executive Commission on China hears testimony about Zero Covid and the human rights abuses its exacerbated in the world’s No. 2 economy. In a report by the Commission, calls for more capital market sanctions.
Here’s How Pharmaceutical Drugs Are Recalled. And Why Some Might Still Remain on the Shelves.
Most people think that when a drug is recalled by the lab, it is pulled from pharmacy shelves. It’s not. Here’s how drug recalls really work.
China’s Five-Year Plan for Biotech Making it Increasingly Attractive for Global Pharma
The China pharmaceutical industry is taking a multi-pronged approach to becoming a dominant player in Asia. Maybe even the world.
FDA Advancements Act Passes Committee, Sets Stage for Fall Reauthorization Passage
The FDA Safety and Landmark Advancements (FDASLA) Act has passed a key committee, with 25 out of some 30 amendments passing. Generics and baby formula crisis got most of the attention.
